Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1nhz | 486 | Glucocorticoid receptor |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1nhz | 486 | Glucocorticoid receptor | / | 1.000 | |
| 2ovh | AS0 | Progesterone receptor | / | 0.542 | |
| 2ovm | AS0 | Progesterone receptor | / | 0.507 | |
| 2w8y | 486 | Progesterone receptor | / | 0.481 | |
| 3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.481 | |
| 5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.460 | |
| 3n0t | OPY | Dipeptidyl peptidase 2 | 3.4.14.2 | 0.451 | |
| 4a2j | AS0 | Progesterone receptor | / | 0.451 | |
| 4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.451 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.449 | |
| 3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.448 | |
| 4dti | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
| 3s79 | ASD | Aromatase | 1.14.14.14 | 0.447 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.445 | |
| 2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
| 4dpd | DHF | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.443 | |
| 4jnc | 1LF | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.442 | |
| 3h18 | PMS | Esterase/lipase | / | 0.440 |